Loading organizations...
Loading organizations...
Cutting-edge genomics and molecular diagnostics company.
NuProbe has raised $103.0M across 3 funding rounds.
NuProbe has raised $103.0M in total across 3 funding rounds.
NuProbe has raised $103.0M in total across 3 funding rounds.
NuProbe's investors include Chen Bing, Jason Zhou, Li Yuhui, Deguan Capital, Haoreng Capital, Hongshan Capital Group (Sequoia Capital China), Pappas Capital, Yonghua Capital, Wen Chen, Juming Capital, Panlin Capital, Ruomu Capital.
NuProbe has raised $103.0M across 3 funding rounds. Most recently, it raised $50.0M Other Equity in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 3, 2022 | $50.0M Other Equity | Chen Bing, Jason Zhou, Li Yuhui | Deguan Capital, Haoreng Capital, Hongshan Capital Group (Sequoia Capital China), Pappas Capital, Yonghua Capital |
| Jan 11, 2021 | $42.0M Other Equity | Wen Chen | Hongshan Capital Group (Sequoia Capital China), Juming Capital, Panlin Capital, Ruomu Capital, Serica Partners, Taifu Capital, Tuobang Capital |
| Apr 23, 2018 | $11.0M Series A | Neil Shen, Victor Chenyang Shi | WuXi AppTec |